Interesting. I don't think I have encountered this during my usage of FLUKA so far. Is there a FLUKA course that deals with this?
_______________________________________________________________________________
Dirk A. Bartkoski, Ph.D.
Research Scientist | Division of Radiation Oncology
T. Boone Pickens Tower (FCT8.5007)
1515 Holcombe Blvd.
Unit 1420
Houston, TX 77030
(713)794-5026
-----Original Message-----
From: me_at_marychin.org [mailto:me_at_marychin.org]
Sent: Thursday, March 30, 2017 8:31 PM
To: Bartkoski,Dirk Alan <DABartkoski_at_mdanderson.org>
Cc: FLUKA Discussion List <fluka-discuss_at_fluka.org>
Subject: Re: [fluka-discuss]: Bremsstrahlung Dose Isolation
The technique is called 'latching'. This is what ISPUSR is for. At every bremsstrahlung event (identified with ICODE in mgdraw.f), set ISPUSR.
This ISPUSR value:
- will remain with the bremsstrahlung photon;
- will be propagated to all the progenies of this bremsstrahlung photon, till the end of the history.
You may then use ISPUSR to filter the dose deposition in comscw.f, and use USRBIN as usual.
ISPUSR is an array. For this purpose only an element of the array is necessary.
:) mary
On 2017-03-31 01:02, Bartkoski,Dirk Alan wrote:
> I am modeling electron beams on water and looking at different dose
> distributions and percent depth dose characteristics. I want to
> separate out the bremsstrahlung contribution to the dose and compare
> the total dose with the bremsstrahlung component. What would be the
> best way to measure only bremsstrahlung dose or the dose without the
> bremsstrahlung?
>
> ______________________________________________________________________
> _________
>
>
> _DIRK A. BARTKOSKI, PH.D._
>
> RESEARCH SCIENTIST | DIVISION OF RADIATION ONCOLOGY
>
> _T. Boone Pickens Tower (FCT8.5007)_
>
> _1515 Holcombe Blvd._
>
> _Unit 1420_
>
> _Houston, TX 77030 _
>
> _(713)794-5026_
>
> The information contained in this e-mail message may be privileged,
> confidential, and/or protected from disclosure. This e-mail message
> may contain protected health information (PHI); dissemination of PHI
> should comply with applicable federal and state laws. If you are not
> the intended recipient, or an authorized representative of the
> intended recipient, any further review, disclosure, use,
> dissemination, distribution, or copying of this message or any
> attachment (or the information contained therein) is strictly
> prohibited. If you think that you have received this e-mail message in
> error, please notify the sender by return e-mail and delete all
> references to it and its contents from your systems.
The information contained in this e-mail message may be privileged, confidential, and/or protected from disclosure. This e-mail message may contain protected health information (PHI); dissemination of PHI should comply with applicable federal and state laws. If you are not the intended recipient, or an authorized representative of the intended recipient, any further review, disclosure, use, dissemination, distribution, or copying of this message or any attachment (or the information contained therein) is strictly prohibited. If you think that you have received this e-mail message in error, please notify the sender by return e-mail and delete all references to it and its contents from your systems.
__________________________________________________________________________
You can manage unsubscription from this mailing list at
https://www.fluka.org/fluka.php?id¬c_info
Received on Mon Apr 03 2017 - 15:26:06 CEST